This book provides a concise introduction to the medicinal chemistry of therapeutically active compounds. Written in an accessible style, it offers a brief overview of the drug development process, from discovery to approved drug.
This book provides a concise introduction to the medicinal chemistry of therapeutically active compounds. Written in an accessible style, it offers a brief overview of the drug development process, from discovery to approved drug.
Norma Dunlap is Professor Emerita of Chemistry at Middle Tennessee State University, where she specialized in synthetic organic chemistry and medicinal chemistry. Her research, done primarily with undergraduates and M.S. students, was focused on design and synthesis of bioactive peptidomimetics. She holds a Ph.D. in organic chemistry from the University of Wyoming and was an NIH postdoctoral fellow at the University of Pennsylvania. She began her career as a Senior Research Scientist at Hoffmann-La Roche, in drug discovery. After moving to academia, she was a Lecturer at Vanderbilt University before moving to Middle Tennessee State University. Donna M. Huryn is Professor of Practice in the Chemistry Department at the University of Pennsylvania where her research focuses on medicinal chemistry projects on novel drugs to treat kidney disease, cancer and rare genetic diseases. She holds a Ph.D. from the University of Pennsylvania. She started her career in industry at Hoffmann-LaRoche and then Wyeth Research before joining academia; she was previously a faculty member at the University of Pittsburgh School of Pharmacy. She is a Fellow of the American Association for the Advancement of Science and the American Chemical Society and was inducted into the ACS Division of Medicinal Chemistry Hall of Fame. She is recipient of the ACS Philadelphia Local Section Award, the Philip S. Portoghese Lectureship, and the Garvin-Olin Medal. From 2014-2023 was Associate Editor of ACS Medicinal Chemistry Letters. In 2019, she co-founded Empowering Women in Organic Chemistry (EWOC), and continues to serve on the organizing committee.
Inhaltsangabe
PART I: DRUG DISCOVERY AND DEVELOPMENT Chapter 1: Historical Perspective and Overview of Drug Discovery Chapter 2: Drug Discovery: Hit and Lead Identification Chapter 3: Lead Optimization: Drug-Target Interactions and the Pharmacophore Chapter 4: Lead Optimization: Properties Optimized and Medicinal Chemistry Strategies Chapter 5: The Process of Developing a Drug from an Optimized Lead PART II: CLASSES OF DRUG TARGETS Chapter 6: Receptors, Ion Channels, and Transporters as Drug Targets Chapter 7: Enzymes as Drug Targets Chapter 8: Protein-Protein and Lipid Structure Interactions as Drug Targets Chapter 9: DNA and RNA as Drug Targets PART III: SELECTED THERAPEUTIC AREAS Chapter 10: Anti-Cancer Drugs Chapter 11: Antiviral and Antifungal Agents Chapter 12: Antibacterial and Antiparasitic Drugs Chapter 13: Drugs Acting on the Central Nervous System
PART I: DRUG DISCOVERY AND DEVELOPMENT Chapter 1: Historical Perspective and Overview of Drug Discovery Chapter 2: Drug Discovery: Hit and Lead Identification Chapter 3: Lead Optimization: Drug-Target Interactions and the Pharmacophore Chapter 4: Lead Optimization: Properties Optimized and Medicinal Chemistry Strategies Chapter 5: The Process of Developing a Drug from an Optimized Lead PART II: CLASSES OF DRUG TARGETS Chapter 6: Receptors, Ion Channels, and Transporters as Drug Targets Chapter 7: Enzymes as Drug Targets Chapter 8: Protein-Protein and Lipid Structure Interactions as Drug Targets Chapter 9: DNA and RNA as Drug Targets PART III: SELECTED THERAPEUTIC AREAS Chapter 10: Anti-Cancer Drugs Chapter 11: Antiviral and Antifungal Agents Chapter 12: Antibacterial and Antiparasitic Drugs Chapter 13: Drugs Acting on the Central Nervous System
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826